# Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer

> **NCT07166003** · — · RECRUITING · sponsor: **Cancer Institute and Hospital, Chinese Academy of Medical Sciences** · enrollment: 500 (estimated)

## Conditions studied

- Lung Cancer, Non-Small Cell
- Immunotherapy

## Interventions

- **PROCEDURE:** Pneumonectomy
- **PROCEDURE:** lobectomy
- **RADIATION:** radiotherapy
- **DRUG:** Anti-Tumor Drugs

## Key facts

- **NCT ID:** NCT07166003
- **Lead sponsor:** Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-20
- **Primary completion:** 2027-02-02
- **Final completion:** 2030-04-14
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07166003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07166003, "Efficacy of Neoadjuvant Immunotherapy in Patients With Lung Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07166003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*